Mohan, A.K., Cote, T.R., Block, J.A., Manadan, A.M., Siegel, J.N. and Braun, M.M. (2004) Tuberculosis Following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor. Clinical Infectious Diseases, 39, 295-299. http://dx.doi.org/10.1086/421494

has been cited by the following article:

• TITLE: Tuberculous Peritonitis Mimicking Malignancy during Adalimumab Therapy in a Patient with Rheumatoid Arthritis

  AUTHORS: Refik Demirtunç, Uğur Özensoy, Kadir Kayataş, Fügen Vardar Aker

  KEYWORDS: Adalimumab, Rheumatoid Arthritis, Tuberculous Peritonitis

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.3 No.3, August 27, 2015

  ABSTRACT: We present a case of tuberculous peritonitis in a 46-year-old woman with rheumatoid arthritis treated with adalimumab, and we review the association between anti-tumour necrosis factor therapy and tuberculosis. This case illustrates that tuberculosis can develop with atypical clinic and uncertain laboratory findings and may mimic malignancies during adalimumab therapy.